Skip to main content

Integer to Exhibit at 2021 MD&M West Expo, Aug. 10-12

~ Learn More About Integer’s Range of Innovative Medical Device Outsourcing Capabilities at Booth #2951 ~

PLANO, Texas, Aug. 09, 2021 (GLOBE NEWSWIRE) — Integer Holdings Corporation (NYSE: ITGR), a leading medical device outsource (MDO) manufacturer, will join medtech industry leaders and innovators around the world in exhibiting at the MD&M West Exposition at the Anaheim Convention Center in Anaheim, Calif., from Aug. 10-12, 2021.

During the event, attendees are invited to visit Integer at booth #2951 to learn more about Integer’s breadth and depth of innovative medical device manufacturing, design and development capabilities. Some highlights include:

  • Xcellion® Rechargeable Batteries: Integer’s new Xcellion® Gen 3 Lithium Ion Fast Charge Rechargeable Batteries deliver leading performance for implantable pulse generators (IPGs) and other medical devices. Xcellion® Gen 3 batteries reduce charging time by up to 70 percent*, increase battery runtime by up to 30 percent* and retain 70 percent original capacity after 6,000+ full cycles.
  • Expanded Laser Cutting Capabilities: Integer’s state-of-the-art manufacturing equipment features the best available technologies including fiber laser, femtosecond lasers, swiss lasers and more. The company’s dedicated engineers apply their expertise to a broad range of product applications, including NiTi frames for EP catheters and stone retrieval devices, support structures for clot retrieval devices, endoscope components, stents, heart valve scaffolds, laser cut hypotubes for peripheral vascular, neurovascular, and structural heart catheters and delivery systems.
  • Comprehensive Leads Solutions: Integer’s proven end-to-end design, development and scalable manufacturing solutions accelerate and optimize customers’ leads programs. This includes designing and developing full lead systems and sub-assemblies, vertically integrated manufacturing as well as customizable services to complement customers’ existing capabilities.

“We take great pride in our capabilities and commitment to serving as a trusted and innovative partner to our customers and their patients,” said Joel Becker, president of Integer’s Cardiac Rhythm Management and Neuromodulation business. “Integer’s continued growth and expansion are a testament to this commitment. We look forward to the opportunity to connect at MD&M West.”

Learn more about Integer at www.integer.net.

*Compared to Xcellion® Gen 2 technology

About Integer®
Integer Holdings Corporation (NYSE: ITGR) is one of the largest medical device outsource (MDO) manufacturers in the world serving the cardiac, neuromodulation, vascular, portable medical, advanced surgical and orthopedics markets. The company provides innovative, high-quality medical technologies that enhance the lives of patients worldwide. In addition, it develops batteries for high-end niche applications in energy, military, and environmental markets. Greatbatch Medical®, Lake Region Medical® and Electrochem® comprise the company’s brands. Additional information is available at www.integer.net.

Investor Relations
Tony Borowicz
tony.borowicz@integer.net
716.759.5809
 
Media Relations
Kelly Butler
kelly.butler@integer.net
214.618.4216

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.